FDA Wants Simpler Language On Drug Promos
The U.S. Food and Drug Administration on Friday tweaked its policies on how risks should be explained in prescription drug advertisements and promotional labeling, marking its latest bid to ensure disclosures...To view the full article, register now.
Already a subscriber? Click here to view full article